Literature DB >> 28600090

Hemodynamics of Cardiogenic Shock.

Ariel Furer1, Jeffrey Wessler2, Daniel Burkhoff3.   

Abstract

Cardiogenic shock (CS) represents an advanced state of morbidity along the pathophysiologic pathway of end-organ hypoperfusion caused by reduced cardiac output and blood pressure. Acute coronary syndromes remain the most common cause of CS. The spectrum of hypoperfusion states caused by low cardiac output ranges from pre-CS to refractory CS and can be characterized by an array of hemodynamic parameters. This review provides the foundation for a hemodynamic understanding of CS including the use of hemodynamic monitoring for diagnosis and treatment, the cardiac and vascular determinants of CS, and a hemodynamic approach to risk stratification and management of CS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiogenic shock; Hemodynamic; Hypoperfusion; Pressure-volume loops; Right heart catheterization

Mesh:

Year:  2017        PMID: 28600090     DOI: 10.1016/j.iccl.2017.03.006

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN: 2211-7458


  9 in total

1.  The Nomenclature, Definition and Distinction of Types of Shock.

Authors:  Thomas Standl; Thorsten Annecke; Ingolf Cascorbi; Axel R Heller; Anton Sabashnikov; Wolfram Teske
Journal:  Dtsch Arztebl Int       Date:  2018-11-09       Impact factor: 5.594

Review 2.  ECMO and Short-term Support for Cardiogenic Shock in Heart Failure.

Authors:  Mathew Jose Chakaramakkil; Cumaraswamy Sivathasan
Journal:  Curr Cardiol Rep       Date:  2018-08-16       Impact factor: 2.931

Review 3.  Pathophysiology and Advanced Hemodynamic Assessment of Cardiogenic Shock.

Authors:  Michael I Brener; Hannah R Rosenblum; Daniel Burkhoff
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jan-Mar

Review 4.  Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?

Authors:  Ivan David Lozada Martinez; Andrea Juliana Bayona-Gamboa; Duvier Fabián Meza-Fandiño; Omar Andrés Paz-Echeverry; Ángela María Ávila-Bonilla; Mario Javier Paz-Echeverry; Frank Jaider Pineda-Trujillo; Gina Paola Rodríguez-García; Jaime Enrique Covaleda-Vargas; Alexis Rafael Narvaez-Rojas
Journal:  Ann Med Surg (Lond)       Date:  2022-09-22

Review 5.  Management of cardiogenic shock complicating myocardial infarction.

Authors:  Alexandre Mebazaa; Alain Combes; Sean van Diepen; Alexa Hollinger; Jaon N Katz; Giovanni Landoni; Ludhmila Abrahao Hajjar; Johan Lassus; Guillaume Lebreton; Gilles Montalescot; Jin Joo Park; Susanna Price; Alessandro Sionis; Demetris Yannopolos; Veli-Pekka Harjola; Bruno Levy; Holger Thiele
Journal:  Intensive Care Med       Date:  2018-05-16       Impact factor: 17.440

Review 6.  Cardiogenic Shock: Recent Developments and Significant Knowledge Gaps.

Authors:  Hiren Patel; Haider Nazeer; Neil Yager; Joshua Schulman-Marcus
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-24

7.  Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.

Authors:  Nikhil Narang; Mark Dela Cruz; Teruhiko Imamura; Ben Chung; Ann B Nguyen; Luise Holzhauser; Bryan A Smith; Sara Kalantari; Jayant Raikhelkar; Nitasha Sarswat; Gene H Kim; Valluvan Jeevanandam; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  Clin Cardiol       Date:  2021-03-18       Impact factor: 2.882

8.  Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry): Observational and Retrospective Study.

Authors:  Alexander Truesdell; Behnam Tehrani; Ramesh Singh; Charles Murphy; Patricia Saulino
Journal:  JMIR Res Protoc       Date:  2018-06-28

Review 9.  Risk stratification in cardiogenic shock: a focus on the available evidence.

Authors:  C Sciaccaluga; G E Mandoli; N Ghionzoli; F Anselmi; C Sorini Dini; F Righini; F Cesareo; F D'Ascenzi; M Focardi; S Valente; M Cameli
Journal:  Heart Fail Rev       Date:  2021-07-14       Impact factor: 4.654

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.